National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 62749-62750 [2020-21947]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 193 / Monday, October 5, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences
Subcommittee.
Date: November 6, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH/NICHD, 6710B Rockledge Dr.,
Bethesda, MD 21157 (Virtual Meeting).
Contact Person: Christiane M. Robbins,
Scientific Research Officer, Scientific Review
Branch (SRB), DER, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, DHHS, 6710B
Rockledge Drive, Rm. 2121B, Bethesda, MD
20817, 301–451–4989, crobbins@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 30, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21942 Filed 10–2–20; 8:45 am]
BILLING CODE 4140–01–P
Date: October 29, 2020.
Time: 1:15 p.m. to 4:15 p.m.
Agenda: OAR Director’s Report; updates
from the HIV Antiretroviral and
Opportunistic Infections Guidelines Working
Groups of OARAC ; discussion of the
transition from AIDSinfo.gov to
HIVinfo.nih.gov; updates from the COVID–19
and HIV taskforce; presentation and report
regarding OAR listening sessions to date;
updates from NIH HIV-related advisory
councils and public comment.
Place: Office of AIDS Research, National
Institutes of Health, 5601 Fishers Lane, Room
2E40, Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mary T. Glenshaw, Ph.D.,
MPH, Senior Science Advisor, Office of AIDS
Research, National Institutes of Health, 5601
Fishers Lane, Room 2E40, Rockville, MD
20850, mary.glenshaw@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 29, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSKJLSW7X2PROD with NOTICES
meeting of the Office of AIDS Research
Advisory Council.
The meeting will be open to the
public via NIH Videocast. The URL link
to this meeting is https://
videocast.nih.gov/watch=38731.
Individuals who need special
assistance, or reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
National Institutes of Health
[FR Doc. 2020–21943 Filed 10–2–20; 8:45 am]
Office of the Director, National
Institutes of Health; Notice of Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
VerDate Sep<11>2014
23:42 Oct 02, 2020
Jkt 253001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
62749
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Mentored Career Development Awards—K23.
Date: November 5, 2020.
Time: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20814 (Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–Y,
Bethesda, MD 20892, (301) 827–7911,
lindsay.garvin@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Sickle Pan-African Consortium.
Date: November 5, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20814 (Virtual Meeting).
Contact Person: Tony L. Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 207–Q,
Bethesda, MD 20892–7924, (301) 827–7913,
creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Grant Review for NHLBI K Award Recipients
(R03).
Date: November 12, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20814 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
E:\FR\FM\05OCN1.SGM
05OCN1
62750
Federal Register / Vol. 85, No. 193 / Monday, October 5, 2020 / Notices
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP (UG3, U24, R34).
Date: November 18, 2020.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20814 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 207–
P, Bethesda, MD 20892–7924, (301) 827–
7942, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Physician Scientists—Research Award for
Early Stage Investigators.
Date: November 19, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–Y,
Bethesda, MD 20892, (301) 827–7911,
lindsay.garvin@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Early Phase Clinical Trials (R61, R33).
Date: November 19, 2020.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20814 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 207–
P, Bethesda, MD 20892–7924, (301) 827–
7942, lismerin@nhlbi.nih.gov.
jbell on DSKJLSW7X2PROD with NOTICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 30, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21947 Filed 10–2–20; 8:45 am]
VerDate Sep<11>2014
23:42 Oct 02, 2020
ACTION:
National Institutes of Health
SUMMARY:
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Career Development (Ks)
and Conference support (R13) Review.
Date: November 10, 2020.
Time: 9:30 a.m. to 05:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John P Holden, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, Bethesda, MD
20892, (301) 496–8775, john.holden@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: September 30, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21946 Filed 10–2–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2020–0098]
Collection of Information Under
Review by Office of Management and
Budget; OMB Control Number 1625–
0002
AGENCY:
BILLING CODE 4140–01–P
Jkt 253001
Thirty-day notice requesting
comments.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Coast Guard, DHS.
Frm 00061
Fmt 4703
Sfmt 4703
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding an
Information Collection Request (ICR),
abstracted below, to the Office of
Management and Budget (OMB), Office
of Information and Regulatory Affairs
(OIRA), requesting an extension of its
approval for the following collection of
information: 1625–0002, Applications
for Vessel Inspection, Waiver, and
Continuous Synopsis Record; without
change. Our ICR describes the
information we seek to collect from the
public. Review and comments by OIRA
ensure we only impose paperwork
burdens commensurate with our
performance of duties.
DATES: You may submit comments to
the Coast Guard and OIRA on or before
November 4, 2020.
ADDRESSES: Comments to the Coast
Guard should be submitted using the
Federal eRulemaking Portal at https://
www.regulations.gov. Search for docket
number [USCG–2020–0098]. Written
comments and recommendations to
OIRA for the proposed information
collection should be sent within 30 days
of publication of this notice to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from: Commandant
(CG–6P), Attn: Paperwork Reduction
Act Manager, U.S. Coast Guard, 2703
Martin Luther King Jr. AVE. SE, Stop
7710, Washington, DC 20593–7710.
FOR FURTHER INFORMATION CONTACT: A.L.
Craig, Office of Privacy Management,
telephone 202–475–3528, or fax 202–
372–8405, for questions on these
documents.
SUPPLEMENTARY INFORMATION:
Public Participation and Request for
Comments
This notice relies on the authority of
the Paperwork Reduction Act of 1995;
44 U.S.C. chapter 35, as amended. An
ICR is an application to OIRA seeking
the approval, extension, or renewal of a
Coast Guard collection of information
(Collection). The ICR contains
information describing the Collection’s
purpose, the Collection’s likely burden
on the affected public, an explanation of
the necessity of the Collection, and
other important information describing
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 85, Number 193 (Monday, October 5, 2020)]
[Notices]
[Pages 62749-62750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21947]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Mentored Career Development Awards--K23.
Date: November 5, 2020.
Time: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20814 (Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-Y, Bethesda, MD 20892, (301) 827-7911,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Sickle Pan-African Consortium.
Date: November 5, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20814 (Virtual Meeting).
Contact Person: Tony L. Creazzo, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 207-Q, Bethesda, MD 20892-7924, (301) 827-7913,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Grant Review for NHLBI K Award Recipients
(R03).
Date: November 12, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20814 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
[[Page 62750]]
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Clinical Trials SEP (UG3, U24, R34).
Date: November 18, 2020.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20814 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 207-P, Bethesda, MD 20892-7924, (301) 827-7942,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Physician Scientists--Research Award for
Early Stage Investigators.
Date: November 19, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-Y, Bethesda, MD 20892, (301) 827-7911,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Early Phase Clinical Trials (R61, R33).
Date: November 19, 2020.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20814 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 207-P, Bethesda, MD 20892-7924, (301) 827-7942,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 30, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-21947 Filed 10-2-20; 8:45 am]
BILLING CODE 4140-01-P
